MET and neoplasm: In contrast to RPTEC, global EGFR and MET activities showed less activity in the FLCN-negative UOK257 tumor cell line when compared with the FLCN-restored UOK257-2, even though EGFR and MET emerge as significantly important pathways in each cell model.